CHEK2 Germline Gene Variant in a Patient with a Somatotrophinoma and Primary Hyperparathyroidism – A Novel MEN1-like Syndrome?

Endocrine Oncology · Published 2026-07-29 · DOI 10.1530/eo-25-0100

Free full text

Authors (13)

Durairaj Arjunan, Mohammad Hayat Bhat, Ashutosh Rai, Vaishali Kaur, Sayka Barry, Md Ejaz Alam, Mohammad Salem Baba, Ajay Gulati, Debajyoti Chatterjee, Manzoor Ahmad Latoo, Márta Korbonits, Ashley Grossman, Pinaki Dutta

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Arjunan, D., Bhat, M., Rai, A., et al. (2026). CHEK2 Germline Gene Variant in a Patient with a Somatotrophinoma and Primary Hyperparathyroidism – A Novel MEN1-like Syndrome?. Endocrine Oncology. https://doi.org/10.1530/eo-25-0100

Related articles

• HbA1c screening in patients with early breast cancer receiving endocrine therapy · Endocrine Oncology · 2025 · Same journal
• Survival and prognostic differences between appendiceal NETs and goblet cell adenocarcinomas · Endocrine Oncology · 2025 · Same journal
• Risk of bowel ischemia in patients with mesenteric neuroendocrine tumors after treatment with 177Lu-DOTATATE · Endocrine Oncology · 2025 · Same journal
• 177Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) in metastatic phaeochromocytomas and paragangliomas (mPPGL): a single centre retrospective analysis of experience at an ENETS Centre of Excellence · Endocrine Oncology · 2025 · Same journal
• Cytologically non-malignant thyroid nodules with three or more high-risk genetic mutations have poor outcomes · Endocrine Oncology · 2025 · Same journal
• To screen or not to screen: complexity of SDHA mutation management · Endocrine Oncology · 2026 · Same journal
• Adrenal crisis due to pembrolizumab-induced hypophysitis in a patient with triple-negative breast cancer · Endocrine Oncology · 2025 · Same journal
• Using routinely collected patient data to study the impact of type 2 diabetes on breast cancer · Endocrine Oncology · 2025 · Same journal
• Patient-reported symptom and urgent healthcare use in neuroendocrine tumors · Endocrine Oncology · 2026 · Same journal
• Gastric neuroendocrine neoplasms: analysis of a cohort of patients followed at the Brazilian National Cancer Institute · Endocrine Oncology · 2025 · Same journal